3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Empowering biomedical learners to navigate FDA regulatory processes and entrepreneurship with a novel interdisciplinary training approach

      methods-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          For rising professionals to meet the needs of contemporary healthcare and biomedical innovation, educators must develop new teaching and learning approaches. Specifically, biomedical innovations are significantly influenced by the FDA’s regulatory framework, requiring professionals to be equipped with regulatory science knowledge, entrepreneurial skills, and interdisciplinary training. However, biomedical education often fails to integrate these skills in an environment that mimics the interdisciplinary setting required for translational science, leaving learners unprepared for unique challenges in practice. This study details an FDA Regulation and Entrepreneurship curriculum at Case Western Reserve University and its affiliated community, leveraging a novel approach for biomedical education. Focused on preparing biomedical professionals to navigate FDA regulatory processes and innovative entrepreneurship endeavors, the curriculum is built upon five core principles: integrating multiple disciplines, ensuring real world applicability, developing a systems thinking approach, incorporating ethical considerations, and fostering a collaborative and experiential learning environment. These principles are supported by a flexible course format, targeted learning objectives, team-based learning sessions, experiential learning opportunities, a diverse participant population, and an interdisciplinary team of faculty and experts. High participant engagement and broad representation across fields over the curriculum’s three-year lifespan to date affirm its relevance and value with participants representing the fields of basic science, medicine, law, business, and engineering. The flexible course format, team-based learning, and experiential learning proved instrumental in enhancing engagement, reinforcing practical learning outcomes, and supporting personalized learning goals. The flexible course format further aligns with professional needs of participants, providing a model for other institutions navigating similar challenges in biomedical education. In conclusion, participant feedback demonstrated the value of the interdisciplinary and transdisciplinary training approach in promoting knowledge retention and skill development in complex medical, business management and legal contexts. Moving forward, targeted outreach and flexible engagement options will be necessary to expand the curricular reach and diverse participant population. The success of the curriculum suggests promising implications for similar approaches aimed at empowering biomedical professionals with essential regulatory, entrepreneurial and interdisciplinary competencies, ultimately advancing translational science and improving healthcare outcomes.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: not found
          • Article: not found

          Health professionals for a new century: transforming education to strengthen health systems in an interdependent world.

            • Record: found
            • Abstract: found
            • Article: not found

            FDA Approval and Regulation of Pharmaceuticals, 1983-2018

            US law requires testing of new drugs before approval to ensure that they provide a well-defined benefit that is commensurate with their risks. A major challenge for the US Food and Drug Administration (FDA) is to achieve an appropriate balance between rigorous testing and the need for timely approval of drugs that have benefits that outweigh their risks.
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Drugs, Devices, and the FDA: Part 1

              Summary Over the last 150 years, the U.S. Food and Drug Administration (FDA) has evolved from a small division of the U.S. Patent Office to 1 of the largest consumer protection agencies in the world. Its mission includes ensuring that new medical treatments reach the public as quickly as possible while simultaneously ensuring that new treatments are both safe and effective. In the face of urgent consumer need, the FDA has faced criticism that its processes are too lengthy and costly and that the time to new drug release is significantly longer in the United States than in other Western countries. Calls from the public to loosen FDA regulations to facilitate more rapid approval of drugs and devices have been countered by the occurrence of patient harm and deaths after some approved drugs have reached the marketplace. New drug and device approval in the United States take an average of 12 and 7 years, respectively, from pre-clinical testing to approval. Costs for development of medical devices run into millions of dollars, and a recent study suggests that the entire cost for a new drug is in excess of $1 billion. For investigators seeking approval for new drugs and devices, FDA processes can be formidable. This 2-part series is intended to provide an overview of the steps involved in bringing new drugs and devices through the FDA process. Part 1 concerns the process of new drug approvals. Part 2 continues with approval of medical devices.

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/827765/overviewRole: Role: Role: Role: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2881011/overviewRole: Role: Role: Role: Role: Role: Role: Role: Role:
                Journal
                Front Med (Lausanne)
                Front Med (Lausanne)
                Front. Med.
                Frontiers in Medicine
                Frontiers Media S.A.
                2296-858X
                06 February 2025
                2025
                : 12
                : 1522572
                Affiliations
                [1] 1Department of Design, Innovation and Organizational Behavior, Weatherhead School of Management, Case Western Reserve University , Cleveland, OH, United States
                [2] 2Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University , Cleveland, OH, United States
                [3] 3Department of Pharmacology and Center for Medical Education, School of Medicine, Case Western Reserve University , Cleveland, OH, United States
                Author notes

                Edited by: Bobbie Ann Adair White, MGH Institute of Health Professions, United States

                Reviewed by: Adamantios Koumpis, University Hospital of Cologne, Germany

                Orin Chisholm, The University of Sydney, Australia

                *Correspondence: Philip A. Cola, pac4@ 123456case.edu
                Tawna L. Mangosh, tlw64@ 123456case.edu

                These authors have contributed equally to this work and share first authorship

                Article
                10.3389/fmed.2025.1522572
                11839641
                39981093
                32b3946f-2577-42db-aea4-565321793562
                Copyright © 2025 Cola and Mangosh.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 04 November 2024
                : 24 January 2025
                Page count
                Figures: 3, Tables: 2, Equations: 0, References: 28, Pages: 10, Words: 7080
                Funding
                The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The curriculum development and publication of this manuscript was funded in part by a gracious couple and alumni of Case Western Reserve University School of Medicine passionate about promoting biomedical innovation through interdisciplinary collaboration. The philanthropic gift provided financial support to the two authors to develop and administer the interdisciplinary curriculum and associated evaluation plan.
                Categories
                Medicine
                Curriculum, Instruction, and Pedagogy
                Custom metadata
                Healthcare Professions Education

                interdisciplinary,transdisciplinary,innovations in biomedical education,regulatory science,entrepreneurship

                Comments

                Comment on this article

                Related Documents Log